Literature DB >> 21615876

Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.

Tetsuhide Ito1, Taichi Nakamura, Nao Fujimori, Yusuke Niina, Hisato Igarashi, Takamasa Oono, Masahiko Uchida, Ken Kawabe, Ryoichi Takayanagi, Isao Nishimori, Makoto Otsuki, Tooru Shimosegawa.   

Abstract

OBJECTIVE: Although patients with autoimmune pancreatitis (AIP) tend to have concurrent diverse disorders, very few studies have focused on diabetes mellitus (DM) coexisting with AIP.
METHODS: In total 102 AIP patients with DM were divided into three groups. Those with DM before the onset of AIP were labeled group A (n=35), those who developed DM and AIP simultaneously were labeled group B (n=58) and those who developed DM after steroid therapy for AIP were labeled group C (n=9). The characteristics of DM among the three groups were evaluated.
RESULTS: No significant differences were noted in the age of DM onset among the three groups. However, the mean duration of DM was significantly longer in group A (8.7 years) than in groups B and C. AIP developed 6.8 years after DM onset in group A, whereas it developed 1.8 years after steroid therapy in group C. Group A had the highest rate (25.7%) of family members with a history of AIP. Levels of serum albumin, total cholesterol and triglyceride were significantly lower in group A. No correlations were found between glycated hemoglobin and benzoyl-tyrosyl para-aminobenzoic acid. Hypoglycemia was observed in 20% of patients under insulin therapy. Most of them were habitual drinkers and received no pancreatic enzymes. Group A showed a high prevalence of retinopathy, nephropathy and macrovascular disorders than group B.
CONCLUSION: Aspects of AIP-associated pancreatic diabetes were clarified. AIP-associated DM must be controlled by a full assessment of the pancreatic endocrine and exocrine function.
© 2011 The Authors. Journal of Digestive Diseases © 2011 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615876     DOI: 10.1111/j.1751-2980.2011.00498.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  13 in total

Review 1.  Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

2.  Impact of hyperglycemia on autoimmune pancreatitis and regulatory T-cells.

Authors:  Franz-Tassilo Müller-Graff; Brit Fitzner; Robert Jaster; Brigitte Vollmar; Dietmar Zechner
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

3.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

Review 4.  Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management.

Authors:  Raghuwansh P Sah; Suresh T Chari
Journal:  Curr Gastroenterol Rep       Date:  2012-04

5.  Exocrine and Endocrine Insufficiency in Autoimmune Pancreatitis: A Matter of Treatment or Time?

Authors:  Sara Nikolic; Patrick Maisonneuve; Ingrid Dahlman; J-Matthias Löhr; Miroslav Vujasinovic
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

6.  IgG4-related disease in endocrine practice.

Authors:  Agata Rzepecka; Anna Babińska; Krzysztof Sworczak
Journal:  Arch Med Sci       Date:  2017-10-20       Impact factor: 3.318

7.  Type 1 Autoimmune Pancreatitis in a Young Male.

Authors:  Farooq Mohyud Din Chaudhary; Asim Tameez Ud Din; Khaleeq Siddiqui; Asma Tameez Ud Din; Sana Mohyud Din Chaudhary
Journal:  Cureus       Date:  2020-04-15

8.  Pseudotumoral Lesion as a Manifestation of Autoimmune Pancreatitis.

Authors:  Catarina Parente; Rúben Reis; Daniela Rodrigues; António Cardoso; Joaquim Peixoto
Journal:  Cureus       Date:  2021-03-16

Review 9.  Autoimmune pancreatitis: What we know so far.

Authors:  Muaaz Masood
Journal:  JGH Open       Date:  2021-12-10

Review 10.  Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.

Authors:  Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Kenichiro Imai; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Yohei Yabuuchi; Masao Yoshida; Naomi Kakushima; Kohei Takizawa; Noboru Kawata; Hiroyuki Ono
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.